WallStSmart

Ethos Technologies Inc. Class A Common Stock (LIFE)vsMarsh & McLennan Companies, Inc. (MRSH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Marsh & McLennan Companies, Inc. generates 5564% more annual revenue ($27.52B vs $485.82M). MRSH leads profitability with a 14.3% profit margin vs -22.1%. MRSH earns a higher WallStSmart Score of 58/100 (C).

LIFE

Hold

45

out of 100

Grade: D

Growth: 10.0Profit: 2.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.29

MRSH

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 7.5Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.74

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LIFE4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
103.5%10/10

Revenue surging 103.5% year-over-year

EPS GrowthGrowth
161.6%10/10

Earnings expanding 161.6% YoY

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

MRSH3 strengths · Avg: 8.7/10
Market CapQuality
$79.75B9/10

Large-cap with strong market position

Return on EquityProfitability
26.9%9/10

Every $100 of equity generates 27 in profit

Operating MarginProfitability
24.3%8/10

Strong operational efficiency at 24.3%

Areas to Watch

LIFE4 concerns · Avg: 2.0/10
Market CapQuality
$1.60B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-24.4%2/10

ROE of -24.4% — below average capital efficiency

Altman Z-ScoreHealth
1.292/10

Distress zone — elevated risk

Profit MarginProfitability
-22.1%1/10

Currently unprofitable

MRSH4 concerns · Avg: 3.3/10
PEG RatioValuation
1.624/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.744/10

Distress zone — elevated risk

Debt/EquityHealth
1.543/10

Elevated debt levels

EPS GrowthGrowth
-15.4%2/10

Earnings declined 15.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : LIFE

The strongest argument for LIFE centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 103.5% demonstrates continued momentum.

Bull Case : MRSH

The strongest argument for MRSH centers on Market Cap, Return on Equity, Operating Margin.

Bear Case : LIFE

The primary concerns for LIFE are Market Cap, Return on Equity, Altman Z-Score.

Bear Case : MRSH

The primary concerns for MRSH are PEG Ratio, Altman Z-Score, Debt/Equity. Debt-to-equity of 1.54 is elevated, increasing financial risk.

Key Dynamics to Monitor

LIFE profiles as a hypergrowth stock while MRSH is a value play — different risk/reward profiles.

LIFE is growing revenue faster at 103.5% — sustainability is the question.

LIFE generates stronger free cash flow (29M), providing more financial flexibility.

Monitor INSURANCE BROKERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MRSH scores higher overall (58/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ethos Technologies Inc. Class A Common Stock

FINANCIAL SERVICES · INSURANCE BROKERS · USA

aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.

Marsh & McLennan Companies, Inc.

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people globally. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?